Unger, Leonore <br/><br/>
Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Sep 2014 
 - 1630-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/keu024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Biomarkers--blood<br/>Creatine Kinase--blood<br/>Dermatomyositis--drug therapy<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Middle Aged<br/>Polymyositis--drug therapy<br/>Prednisolone--administration & dosage<br/>Retrospective Studies<br/>Rituximab<br/>Total Lung Capacity--drug effects<br/>Treatment Outcome